Lacosamide
NDC 53746-923, Lacosamide, tablet, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 53746-923
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204857
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/53746-923 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE50 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53746-923-05 | 53746092305 | 500 TABLET in 1 BOTTLE (53746-923-05) |
| 53746-923-60 | 53746092360 | 60 TABLET in 1 BOTTLE (53746-923-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0e21389b-2f51-4975-aa21-fc5c9dd9f6dc
Use it
Look up 53746-923 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53746-923 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53746-923. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.